当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.1.Inclusion Criteria

Eligible participant has to fullfill all of the following items

/
/
/
/

1.2.Exclusion Criteria

Anyone with one of following items or more should be excluded:

/
/
/
/
/
/
/
/

2.Baseline
2.1.General information

Date of signing the informed consent

2024-2-25

Date of birth

1978-12-26 yyyy-mm-dd

Age

45 Years

Education background

University

Occupation

Doctor

Other (Description)

--

2.2.Medical history

间断1个月 小时

Number of pregnancy

1

Number of delivery

1

If has delivery history, select following items

partus maturus

1

premature delivery

-

abortion

-

Last pregnancy

不详 yyyy-mm-dd

Average times of menstrual onset a year

13 次/年

Average menstrual cycle

7 天(days)

Menarche time

15 岁(years)

The time of last Menstruation

2024-2-20 年、月、日(yyyy-mm-dd)

The time of menstrual onset before the last one

不详 年、月、日(yyyy-mm-dd)

--

-- 年/月/日(yyyy-mm-dd)

Namy of the drug to be allergied

2.3.Physical examination

Vulva

Normal

Description in detail for abnormal

2024-2-25

Vagina

Normal

Description in detail for abnormal

2024-2-25

Uterine neck

Normal

Description in detail for abnormal

2024-2-25

Corpus uteri

Normal

Description in detail for abnormal

2024-2-25

Adnexa uteri

Left side

Abnormal

Description in detail for abnormal

增厚

Right side

Abnormal

Description in detail for abnormal

可触及5cm包块

Weight

63 kg

Hight

1630 mm

Systolic pressure (SP)

117 mmHg

Diastolic pressure

76 mmHg

Temperature

36.6 degree Celsius

Pulse rate

88 次/分

Breath frequency

22 次/分

Doctor signature

刘义彬

Date

2024-2-25 yyyy-mm-dd

2.4.Blood Routine Tests

WBC

4.90 ×109 /L

NEUT%

59.88 %

LY%

30.50 %

MONO%

8.07

RBC

4.57 ×10^12 /L

HGB

107 g/L

PLT

285 ×10^9 /L

Researcher signature

刘义彬

Date

2024-2-26 yyyy-mm-dd

2.5.Urine Routine Test

Acidity and allkalinity

Acidity

pH value

7

Urine protein

Negative

Urine red cell

Negative

Urine WBC

Negative

Urine glucos

Negative

Urine Bilirubin

Negative

Urine HCG

KET

Negative

SG

1.031

UBG

Negative

NIT

Negative

Date of test

2024-2-26 yyyy-mm-dd

2.6.Blood Electrolytes Tests

Date of test

2024-2-26 yyyy-mm-dd

K

4.59 mmol/L

Na

143.8 mmol/L

Cl

105.6 mmol/L

Ca

2.23 mmol/L

P

1.40 mmol/L

2.7.Coagulation Function Tests

Date of examination

2024-2-26 yyyy-mm-dd

Prothrombin time

10.9

Thrombin time (TT)

16.6

Activated partial thromboplastin time (APTT)

33.3

Fibrinogen (FIB)

2.29 g/L

2.8.Serum Liver Function Tests

ALT

12.0 IU/L

AST

15.5 IU/L

GGT

12.0 U/L

Serum bilirubin

15.5 μmol/L

Indirect bilirubin

11.50 umol/L

Direct bilirubin

4.0 umol/L

Serum albumin

40.7 g/L

Serum globulin

25.8 g/L

Serum total protein

66.5 g/L

Date of test

2024-2-26 yyyy-mm-dd

2.9.HBV/HCV/HIV/Syphilis Markers Test
2.2.9.2.9.1、HBV Markers Test

Negative

Date of test

2024-2-26 yyyy-mm-dd

2.2.9.2.9.2、HCV Marker Test

Negative

Date of test

2024-2-26 yyyy-mm-dd

2.2.9.2.9.3、HIV Marker Test

Negative

Date of test

2024-2-26 yyyy-mm-dd

2.2.9.2.9.4、Syphilis Marker Test

Negative

Date of test

2024-2-26 yyyy-mm-dd

2.10.Renel Function Test

SCr

67.0 μmol/L

Blood urea

7.5 mmol/L

Blood uric acid

331.0 μmol/L

Date of test

2024--2-26 yyyy-mm-dd

2.11.D-dimer

D-dimer value

0.10 ug/mL

Date of test

2024-2-26

2.12.hCG Test

Urine pregnancy test

Not tested

Blood HCG concentration

-- mIU/mL

Date of test

2024-2-26 yyyy-mm-dd

2.13.Image Examinations
2.2.13.2.13.1、Ultrasound

Size of the ulcer

45.4*4.3*482 cm*cm

Uterine echo distribution

Even

Endometrial thickness

4.2 mm

Left ovary size

3.2*2.1 cm ×cm

Shape of Left ovary

Ovarian cyst

Size of the Ovarian cyst

1.1 1.02 2.1 3个

Right ovary size

6.1*4.2 cm ×cm

Shape of right ovary

Ovarian cyst

Size of Ovarian cyst

5.2cm

Description of other abnormal findings

--

Diagnosis of the Ultrasound B

双卵巢巧囊

Doctor signature

刘义彬

Date of examination

2024-2-27 yyyy-mm-dd

2.2.13.2.13.2、Other examination
2.14.Visual Analogue Scale

Pain Visual Analogue Score

Occasionally very slight pain

2.15.Blood Gas Analysis

PH

未查

PCO2

mmHg

P02

mmHg

SO2

HCO3

未查 mmol/l

SBE

mmol/l

LAC

mmol/L

Date of examination

未查 (yyyy-mm-dd)

3.In the process of the treatment
3.1.Treatment Record

双侧附件

左侧2Cm 右侧5cm cm

-- °

/

刘义彬

2024-3-1

4.Follow-up
4.1.D-dimer

D-dimer value

0.17 ug/mL

Date of test

2024-3-2

4.2.Physical examination

Body temperature

37

Systolic pressure (SP)

116 mmHg

Diastolic pressure (DP)

93 mmHg

Heart Rate, HR

75 次/分

Pulse

75 次/秒

4.3.Blood Routine Tests

WBC

8.1 ×109 /L

NEUT%

75.99 %

LY%

16.26 %

MONO%

7.23

RBC

4.30 ×10^12 /L

HGB

106 g/L

PLT

249 ×10^9 /L

Date

2024-3-2 yyyy-mm-dd

4.4.Visual Analogue Scale

/

Pain Visual Analogue Score

Occasionally very slight pain

5.Speciman management system

sample collection

Collected

Volume

2 ml

Time of collection

2024-2-27 yyyy-mm-dd-hh-min.

Label Number of the sample

2567927

6.ADR/ADE management system

Date received at DCC

-- yyyymmdd

Report type

Name of this event

--

SAE start date

-- yyyymmdd

SAE stop date

-- yyyymmdd

Was this an unanticipated adverse event

Attribution to Study Drug

Outcome Type(check all that apply)

Recovery Description: (check only one)

Please provide a brief narrative of the SAE occurrence below

---

Name of the recorder

Data

yyyymmdd

Site Investigator’s signature

Data

-- yyyymmdd